ATE212356T1 - Carbamoylmethylharnstoffderivate - Google Patents

Carbamoylmethylharnstoffderivate

Info

Publication number
ATE212356T1
ATE212356T1 AT95907849T AT95907849T ATE212356T1 AT E212356 T1 ATE212356 T1 AT E212356T1 AT 95907849 T AT95907849 T AT 95907849T AT 95907849 T AT95907849 T AT 95907849T AT E212356 T1 ATE212356 T1 AT E212356T1
Authority
AT
Austria
Prior art keywords
optionally substituted
receptors
cck
substituted phenyl
heterocyclic group
Prior art date
Application number
AT95907849T
Other languages
English (en)
Inventor
Sanji Hagishita
Susumu Kamata
Yasushi Murakami
Nobuhiro Haga
Yasunobu Ishihara
Toshiro Konoike
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE212356T1 publication Critical patent/ATE212356T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95907849T 1994-02-09 1995-02-07 Carbamoylmethylharnstoffderivate ATE212356T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1518994 1994-02-09
JP24155594 1994-10-05
PCT/JP1995/000161 WO1995021856A1 (en) 1994-02-09 1995-02-07 Carbamoylmethylurea derivative

Publications (1)

Publication Number Publication Date
ATE212356T1 true ATE212356T1 (de) 2002-02-15

Family

ID=26351304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907849T ATE212356T1 (de) 1994-02-09 1995-02-07 Carbamoylmethylharnstoffderivate

Country Status (17)

Country Link
US (1) US5739162A (de)
EP (1) EP0739903B1 (de)
CN (1) CN1145074A (de)
AT (1) ATE212356T1 (de)
AU (1) AU691565B2 (de)
BR (1) BR9506763A (de)
CA (1) CA2181986A1 (de)
DE (1) DE69525145T2 (de)
ES (1) ES2171531T3 (de)
FI (1) FI963122L (de)
HU (1) HU219913B (de)
MX (1) MX9603171A (de)
NO (1) NO963307L (de)
PT (1) PT739903E (de)
RU (1) RU2134684C1 (de)
TW (1) TW294653B (de)
WO (1) WO1995021856A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
ATE206109T1 (de) * 1995-08-07 2001-10-15 Shionogi & Co Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
WO2015009545A1 (en) * 2013-07-16 2015-01-22 Allergan, Inc. Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166355A2 (de) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituierte Aminophenyl- und Acylaminophenyl-Verbindungen und deren pharmazeutische Zusammensetzungen
EP0514442B1 (de) * 1990-02-09 1994-04-27 Aventis Pharma S.A. N-phenyl-n-acetamidoglycinamide, ihre herstellung und medikamente, die sie enthalten
FR2659334B1 (fr) * 1990-03-07 1992-05-15 Rhone Poulenc Sante Derives de n-phenyl glycinamide, leur preparation et les medicaments les contenant.
FR2667864B2 (fr) * 1990-03-07 1994-08-05 Rhone Poulenc Sante Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.

Also Published As

Publication number Publication date
WO1995021856A1 (en) 1995-08-17
EP0739903A4 (de) 1998-07-08
NO963307L (no) 1996-10-09
EP0739903A1 (de) 1996-10-30
AU1590595A (en) 1995-08-29
HU9602187D0 (en) 1996-10-28
MX9603171A (es) 1997-03-29
BR9506763A (pt) 1997-10-07
DE69525145T2 (de) 2002-08-29
DE69525145D1 (en) 2002-03-14
ES2171531T3 (es) 2002-09-16
TW294653B (de) 1997-01-01
HUT74950A (en) 1997-03-28
CN1145074A (zh) 1997-03-12
FI963122A7 (fi) 1996-08-09
US5739162A (en) 1998-04-14
HU219913B (hu) 2001-09-28
CA2181986A1 (en) 1995-08-17
FI963122A0 (fi) 1996-08-09
NO963307D0 (no) 1996-08-08
FI963122L (fi) 1996-08-09
PT739903E (pt) 2002-05-31
AU691565B2 (en) 1998-05-21
RU2134684C1 (ru) 1999-08-20
EP0739903B1 (de) 2002-01-23

Similar Documents

Publication Publication Date Title
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69111816D1 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
ATE172463T1 (de) Pyrrolocarbazol
ZA902668B (en) Tetrahydrobenz(c,d)indole serotonin agonists
NO165072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-vinyl-og 3-ethynyl-8-carbolinderivater.
NZ218243A (en) B-carboline derivatives and pharmaceutical compositions
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
GB2311780A (en) Piperazine-2,5-dione derivatives as modulators of multidrug resistance
ES2173167T3 (es) Derivados de benzodiazepina.
ATE212356T1 (de) Carbamoylmethylharnstoffderivate
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee